These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6171989)

  • 1. Influence of a beta-adrenoceptor stimulant, KWD 2131, in nasal histamine provocation tests. Rhinomanometric evaluations in normal persons and patients with hay fever.
    Svensson G; Hegardt B; Löfkvist T
    Acta Otolaryngol; 1981; 92(5-6):535-41. PubMed ID: 6171989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topical use of beta-adrenoceptor stimulants on nasal mucosa. Rhinomanometric evaluations in experiments with terbutaline and KWD 2131. II. Nasal provocation tests with hay fever patients in asymptomatic period.
    Svensson G
    Acta Otolaryngol; 1980; 90(1-2):130-8. PubMed ID: 6108672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topical use of beta-adrenoceptor stimulants of nasal mucosa. Rhinomanometric evaluations in experiments with terbutaline and KWD 2131.
    Svensson G; Hegardt B; Löfkvist T
    Acta Otolaryngol; 1980; 90(3-4):297-303. PubMed ID: 6110308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of seasonal allergic rhinitis with a beta-adrenoceptor stimulant (KWD 2131).
    Svensson G
    Rhinology; 1982 Sep; 20(3):159-66. PubMed ID: 6127780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming.
    Polosa R; Pagano C; Low JL; Church MK; Crimi N
    Ann Ital Med Int; 1999; 14(2):86-93. PubMed ID: 10399370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
    Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiallergic actions of high topical doses of terbutaline in human nasal airways.
    Svensson C; Greiff L; Andersson M; Alkner U; Grönneberg R; Persson CG
    Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
    Pegelow KO; Strandberg K
    Allergy; 1980 Sep; 35(6):509-19. PubMed ID: 6110383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
    Petersen LJ; Skov PS
    Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal reactions elicited by unilateral allergen challenge.
    Malmberg H; Binder E; Fräki J; Harvima I; Salo O; Holopainen E
    Acta Otolaryngol; 1989; 107(5-6):446-9. PubMed ID: 2474232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
    Hegardt B; Arner B
    Eur J Respir Dis; 1981 Oct; 62(5):352-9. PubMed ID: 6124440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
    Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
    Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.
    Russo C; Zeng D; Prosperini G; Spicuzza L; Guarino F; Polosa R
    Clin Exp Allergy; 2005 Sep; 35(9):1192-6. PubMed ID: 16164447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective property of equipotent bronchodilating doses of inhaled KWD 2131 and terbutaline against allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N; Granerus G
    Allergy; 1982 Aug; 37(6):407-16. PubMed ID: 7137535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-anaphylactic and bronchodilating action of a beta-adrenoceptor stimulator, KWD 2131, in human lung tissue.
    Strandberg K; Pegelow KO; Persson CG; Sörenby L
    Allergy; 1979 Aug; 34(4):221-4. PubMed ID: 92896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis].
    Tahamiler R; Saritzali G; Canakçioğlu S
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):30-6. PubMed ID: 17483609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budesonide and nasal histamine challenge.
    Pipkorn U
    Allergy; 1982 Jul; 37(5):359-63. PubMed ID: 7125153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower respiratory tract complications during nasal provocation: nonspecific stimulant or specific allergen?
    Kirmaz C; Degirmenci PB; Tunali D; Yuksel H
    Ann Allergy Asthma Immunol; 2007 Jun; 98(6):524-32. PubMed ID: 17601264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azelastine reduces histamine-induced swelling of nasal mucosa.
    Spaeth J; Schultze V; Klimek L; Lengersdorf A; Mosges R
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(3):157-63. PubMed ID: 8797220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.